Patent delisted for Astrazeneca Ab drug BYDUREON
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. […]
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. […]
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It
Annual Drug Patent Expirations for NORVIR Norvir is a drug marketed by Abbott, Abbvie, and Abbvie Inc and, and is
Annual Drug Patent Expirations for COPAXONE Copaxone is a drug marketed by Teva Pharms Usa and is included in one
Annual Drug Patent Expirations for ADRENACLICK Adrenaclick is a drug marketed by Impax and is included in one NDA. It
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA.
Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA.
Annual Drug Patent Expirations for BIDIL Bidil is a drug marketed by Arbor Pharms Llc and is included in one
New patent expiration for Arbor Pharms drug BIDIL Read Post »
Get fresh news and insights, drug patent expirations & more…